Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs with biomaterial for delayed union after long bone fracture
2011-005441-13Phase 2Completed
- Sponsor
- Inserm
- Start
- May 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous mesenchymal stem cells in delayed bone healing, long bone fracture, sponsored by Inserm. Started May 2012; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
delayed bone healinglong bone fracture
Beyond the preview
Go deeper on 2011-005441-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005441-13.